Nasdaq Panel grants AREB continued listing conditional on meeting equity rule by Nov 15, 2025

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 29, 2026, the Nasdaq Hearings Panel (the “Panel”) notified Triller Group Inc. (“Triller” or the “Company”) that the Panel determined to grant Triller an exception to the Listing Rules of The Nasdaq Stock Market (“Nasdaq” or the “Exchange”) until June 30, 2026 in order to regain compliance with Listing Rule 5550(a)(2) (the “Bid Price Rule”). As previously disclosed on April 24, 2026, following a successful appeal by the Company to the Nasdaq Stock Market Listing and Hearing Review Council (the “Listing Council”) which modified a previous December 26, 2025 decision by a Nasdaq Hearings Panel

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 19, 2026, Gencor Industries, Inc. (the “Company”) received a notice (the “Delinquency Notification”) from NYSE Regulation (the “NYSE”) indicating the Company was not in compliance with the NYSE American LLC (“NYSE American”) continued listing standards as a result of its failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”) with the Securities and Exchange Commission (“SEC”) prior to May 18, 2026, the end of the extension period provided by Form 12b-25, and as a result was subject to the procedures set forth in Section 1007 of the NY

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 27, 2026, Actinium Pharmaceuticals, Inc. (the “Company”) received a notice (the “Notice”) from NYSE American LLC (“NYSE American”) indicating that the Company is not in compliance with the continued listing standards set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”), which requires a listed company to maintain stockholders’ equity of $4.0 million or more if it has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. As of March 31, 2026, the Company reported stockholders’ equity of approximately

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 26, 2026, Cloudastructure, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (“Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission. The Company requires additional time to review and confirm the accounting treatment for its outstand

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 26, 2026, Gulf Resources (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), indicating that, as a result of not having timely filed its quarterly report on Form 10-Q for the quarter ended March 31, 2026 (the “Form 10-Q”), and the Company remains delinquent in filing its annual report on Form 10-K for the year ended December 31, 2025 (the “Initial Delinquent Filing”), the Company is in non-compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing all required periodic financial reports wit

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 26, 2026, Onfolio Holdings Inc. (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) informing the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice states that the Company’s Quarterly Report on Form 10-Q for the for the period ended March 31, 2026 reported stockholders’ equity of $1,216,603. As of the date of the Notice

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 22, 2026, Richtech Robotics Inc., a Nevada corporation (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), because it has not timely filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “ Form 10-Q ”) with the U.S. Securities and Exchange Commission (the “ SEC ”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Com

This filing

October 20, 2025, the Company received a decision letter from the Nasdaq Hearings Panel (“ Panel ”) granting the Company’s request to continue its listing on The Nasdaq Stock Market LLC (“ Nasdaq ”), subject to the condition that, on or before November 15, 2025, the Company shall demonstrate compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Equity Rule ”). This decision follows the Company’s hearing before the Panel on September 30, 2025, regarding its non-compliance with the Equity Rule. As previously reported in a Current Report on Form 8-K filed on August 20, 2025, the Company received

Comparable filing

May 21, 2026, CDT Equity Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”) because the Company did not file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”) in a timely manner, as required for continued listing on The Nasdaq Capital Market. The Notice has no immediate effect on the listing or trading of the Company’s